Brighton, MA, United States of America

Christian M Gampe

USPTO Granted Patents = 2 

Average Co-Inventor Count = 4.4

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2018

Loading Chart...
2 patents (USPTO):

Title: Christian M Gampe: Innovator in Glycosyltransferase Inhibitors

Introduction

Christian M Gampe is a notable inventor based in Brighton, MA (US). He has made significant contributions to the field of biochemistry, particularly in the development of methods and compounds for identifying glycosyltransferase inhibitors. With a total of 2 patents, his work has implications for antibiotic development and bacterial resistance.

Latest Patents

Gampe's latest patents include "Methods and compounds for identifying glycosyltransferase inhibitors" and "Chemoenzymatic methods for synthesizing moenomycin analogs." The first patent provides moenomycin-based probe compounds for use in screening inhibitors of bacterial glycosyltransferases. It also outlines bacterial glycosyltransferase screening assays utilizing these compounds. The second patent details methods for synthesizing moenomycin analogs and includes compositions and kits for these compounds.

Career Highlights

Christian M Gampe is affiliated with Harvard College, where he conducts his research and development work. His innovative approaches have positioned him as a key figure in his field, contributing to advancements in understanding bacterial mechanisms.

Collaborations

Gampe has collaborated with esteemed colleagues such as Daniel E Kahne and Suzanne Walker Kahne. These partnerships have further enriched his research and expanded the impact of his inventions.

Conclusion

Christian M Gampe's work in the field of glycosyltransferase inhibitors showcases his innovative spirit and dedication to advancing biochemistry. His patents reflect a commitment to addressing critical challenges in antibiotic resistance and bacterial infections.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…